Harbor Capital Advisors, Inc. Orchard Therapeutics PLC Transaction History

Harbor Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$0.42 - $0.78 $99,406 - $184,611	-236,681 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$0.7 - $1.51 $27,432 - $59,175	-39,189 Reduced 14.21%	236,681 $168,000
Q4 2021 Feb 04, 2022	BUY	$1.16 - $2.23 $320,009 - $615,190	275,870 New	275,870 $364,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.